Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
614 Ergebnisse
| MM20EH |  | Vertex Pharmaceuticals Inc./Faktor/Long [10]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 425,409 | 425,409 | - | 10,079 % | - | Morgan Stanley | |
| MM2MHC | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 399,953 | 399,953 | 6,238 | 15,460 % | - | Morgan Stanley | |
| MM2MMQ | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 191,319 | 216,100 | 1,683 | 54,322 % | - | Morgan Stanley | |
| MM2MMR | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 229,635 | 259,320 | 1,948 | 45,186 % | - | Morgan Stanley | |
| MM2MMS | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 248,771 | 280,930 | 2,115 | 40,618 % | - | Morgan Stanley | |
| MM2MMT | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 286,979 | 324,150 | 2,548 | 31,482 % | - | Morgan Stanley | |
| MM2MMU | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 315,748 | 356,560 | 3,017 | 24,632 % | - | Morgan Stanley | |
| MM2MMV | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 325,316 | 367,360 | 3,053 | 22,349 % | - | Morgan Stanley | |
| MM2MMW | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 344,452 | 388,970 | 3,663 | 17,781 % | - | Morgan Stanley | |
| MM2MMX | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 354,020 | 399,780 | 3,945 | 15,496 % | - | Morgan Stanley | |
| MM4DG0 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 294,006 | 332,080 | 2,654 | 29,806 % | - | Morgan Stanley | |
| MM4TW3 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 359,870 | 406,380 | 4,150 | 14,101 % | - | Morgan Stanley | |
| MM59ZK | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 416,556 | 416,556 | - | 11,950 % | - | Morgan Stanley | |
| MN06N3 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 314,081 | 314,081 | 2,953 | 33,611 % | - | Morgan Stanley | |
| MN06N4 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 408,214 | 408,214 | 7,008 | 13,713 % | - | Morgan Stanley | |
| MN07K3 | | Vertex Pharmaceuticals Inc./Faktor/Short [5]/MS | - | - | put | Vertex Pharmaceuticals Inc. | 567,070 | 567,070 | 4,770 | 19,865 % | - | Morgan Stanley | |
| MN1E8H | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 271,030 | 271,030 | 2,322 | 42,711 % | - | Morgan Stanley | |
| MN205U | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 291,417 | 291,417 | 2,608 | 38,401 % | - | Morgan Stanley | |
| MN7SET | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 347,749 | 347,749 | 3,767 | 26,494 % | - | Morgan Stanley | |
| MN93DY | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 244,305 | 244,305 | 2,070 | 48,360 % | - | Morgan Stanley | |
| MN93DZ | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 305,382 | 305,382 | 2,794 | 35,450 % | - | Morgan Stanley | |
| MN9594 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 270,249 | 305,180 | 2,319 | 35,492 % | - | Morgan Stanley | |
| MN971Y | | Vertex Pharmaceuticals Inc./Faktor/Short [2]/MS | - | - | put | Vertex Pharmaceuticals Inc. | 708,838 | 708,838 | - | 49,831 % | - | Morgan Stanley | |
| MN971Z | | Vertex Pharmaceuticals Inc./Faktor/Short [3]/MS | - | - | put | Vertex Pharmaceuticals Inc. | 630,078 | 630,078 | - | 33,183 % | - | Morgan Stanley | |
| MN9L6W | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 264,247 | 264,247 | 2,256 | 44,144 % | - | Morgan Stanley | |
| MR1G6T | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 282,727 | 282,727 | 2,489 | 40,238 % | - | Morgan Stanley | |
| MR1G6U | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 383,788 | 383,788 | 5,208 | 18,876 % | - | Morgan Stanley | |
| MR1G6V | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 424,187 | 424,187 | - | 10,337 % | - | Morgan Stanley | |
| MR1G6W | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 434,286 | 434,286 | - | 8,202 % | - | Morgan Stanley | |
| MR1GDN | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 379,855 | 428,950 | 5,025 | 9,330 % | - | Morgan Stanley | |
| MR1YD1 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 363,015 | 363,015 | 4,278 | 23,267 % | - | Morgan Stanley | |
| MR1YD2 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 393,178 | 393,178 | 5,802 | 16,892 % | - | Morgan Stanley | |
| MR1YD3 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 443,685 | 443,685 | - | 6,215 % | - | Morgan Stanley | |
| MR2E36 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 400,932 | 452,750 | 6,506 | 4,299 % | - | Morgan Stanley | |
| MR2E53 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 452,951 | 452,951 | - | 4,257 % | - | Morgan Stanley | |
| MR2QRV | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 462,389 | 462,389 | - | 2,262 % | - | Morgan Stanley | |
| MR3GBP | | Vertex Pharmaceuticals Inc./Faktor/Short [4]/MS | - | - | put | Vertex Pharmaceuticals Inc. | 590,698 | 590,698 | - | 24,860 % | - | Morgan Stanley | |
| MR3GBQ | | Vertex Pharmaceuticals Inc./Faktor/Short [6]/MS | - | - | put | Vertex Pharmaceuticals Inc. | 551,318 | 551,318 | - | 16,536 % | - | Morgan Stanley | |
| MR4DJV | | Vertex Pharmaceuticals Inc./KO/Put [endlos]/MS | - | - | put | Vertex Pharmaceuticals Inc. | 574,684 | 500,000 | 4,527 | 5,688 % | - | Morgan Stanley | |
| MR4DM3 | | Vertex Pharmaceuticals Inc./KO/Put [endlos]/MS | - | - | put | Vertex Pharmaceuticals Inc. | 499,975 | 499,975 | - | 5,683 % | - | Morgan Stanley | |
| MR4DQY | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 470,106 | 470,106 | - | 0,631 % | - | Morgan Stanley | |
| PJ97B8 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/BNP | - | - | call | Vertex Pharmaceuticals Inc. | 404,801 | 404,801 | 6,682 | 14,435 % | - | BNP Paribas | |
| PJ9V7V | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/BNP | - | - | call | Vertex Pharmaceuticals Inc. | 383,844 | 383,844 | 5,121 | 18,864 % | - | BNP Paribas | |
| PJ9V7W | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/BNP | - | - | call | Vertex Pharmaceuticals Inc. | 362,519 | 362,519 | 4,160 | 23,372 % | - | BNP Paribas | |
| PJ9V7X | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/BNP | - | - | call | Vertex Pharmaceuticals Inc. | 319,870 | 319,870 | 3,024 | 32,387 % | - | BNP Paribas | |
| PJ9V7Y | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/BNP | - | - | call | Vertex Pharmaceuticals Inc. | 266,559 | 266,559 | 2,255 | 43,656 % | - | BNP Paribas | |
| PJ9VQ0 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/BNP | - | - | call | Vertex Pharmaceuticals Inc. | 319,870 | 351,857 | 3,074 | 25,626 % | - | BNP Paribas | |
| PJ9VQ1 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/BNP | - | - | call | Vertex Pharmaceuticals Inc. | 266,559 | 293,215 | 2,282 | 38,021 % | - | BNP Paribas | |
| PK0MKM | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/BNP | - | - | call | Vertex Pharmaceuticals Inc. | 372,251 | 409,476 | 4,666 | 13,446 % | - | BNP Paribas | |
| PK1G6F | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/BNP | - | - | call | Vertex Pharmaceuticals Inc. | 339,338 | 373,271 | 3,520 | 21,099 % | - | BNP Paribas |